ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2372

Effect of Oxytocin on Osteoarthritis

christian roux1, astrid pinzano2, didier Pisani3, Patricia panaia-Ferrari4, eric Fontas5, hedi Ben Yahia6, damien ambrosetti7, jean-François michiels8, veronique Breuil9 and ez Zoubir Amri10, 1Rheumatology, LAMHESS laboratory, sofia antipolis university, CHU Pasteur 2, Nice, France, nice, France, 2IMoPA Ingénierie Moléculaire et Physiopathologie Articulaire, University nancy lorraine, UMR7365 CNRS-UL, Nancy, France, 3CNRS UMR7277, Inserm U1091, UNS Université Nice Sophia Antipolis Parc Valrose, nice, France, 4IBiology and immunology laboratory, university nice sofia antipolis, nice, France, 5Direction recherche clinique, CHU de Nice, france, Nice, France, 6iBV - Institut de Biologie Valrose. Nice, Nice, France, 7Department anatomopathology, nice. university nice sofia antipolis, nice, France, 8department anatomo-pathology, Nice, university nice sofia antipolis, Nice, France, 9Rheumatology department, Nice, France, 10CNRS UMR7277, Inserm U1091, UNS Université Nice Sophia Antipolis Parc Valrose, Nice, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Osteoarthritis – Clinical Aspects - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  The relationship between oxytocine (OT) and osteoarthritis (OA) is poorly studied and remains unknown. However the subchondral bone is considered as a major player in osteoarthritis, and a protective effect of OT on bone mineralization is described in recent studies. The aim of our work was to investigate a possible link between OT and OA.

Methods:  we used three different approaches: i) In vitro using MSC (adipose and bone marrow derived stem cells) that were maintained as mono-layer (2D) or as pellets in three dimension (3D) in the absence or the presence of OT. RT-PCR, histological and immunohistochemical analysis were performed. ii) in vivo using a rat animal model developing OA upon anterior cruciate ligament transection (ACLT) . Twenty female Wistar rats were divided in 2 groups: one group was sham operated whereas the second was ACL transected. Half of each group received either OT (1 mg/kg/day) injections or saline buffer. Histological analysis was performed on day 28. The severity of OA lesions was assessed on a scale adapted from Mankin’s score at medial part of the femur. iii) Clinical analysis using a human cohort. Samples issued from a hand OA cohort (ADEM). 63 OA women have been included; men were excluded because of their low number. At baseline, all subjects benefited of OT and leptin circulating levels measurements and hand X rays (Scoring systems including Kelgren and Lawrence and Verbruggen scores). The control group consists in subjects of the same age range without osteoporosis, OA or inflammatory disease.

Results: OT treatment of differentiating MSCs for 21 days induced a significant increase of agrecan, Col X and COMP mRNA levels without variation of Col 1a. Immunostaining experiments showed an improvement of Sox9 and Col II expression in the presence of OT. The histological analysis of rat knee showed no differences in the severity of lesions between the different ACLT groups. The characteristics of the women cohorts is as follow: 63 OA women age=65 (+/-11), Body Mass Index (BMI) = 24(+/-4), OT=1.4 (+/-2) and 19 control women age=63(+/-10), BMI=26(+/-5), OT=6.5(+/-7).The multivariate analysis adjusted for age, BMI and leptin levels, showed a significant lower level of OT in hand OA women (p=0.002, β=3.4). In univariate analysis, there was no relationship between OT blood levels and the severity of OA (Verbruggen:p=0.7, KL:p=0.2), Joint Space Narrowing (p=0.2) and osteophytes (p=0.1).

Conclusion:  Our study shows an anabolic effect of OT on chondrogenesis and that OT circulating levels was significantly lower in OA patients. OT might represents an interesting player in the pathophysiology of osteoarthritis and further studies will shed some light on its mechanism of action.


Disclosure: C. roux, None; A. pinzano, None; D. Pisani, None; P. panaia-Ferrari, None; E. Fontas, None; H. Ben Yahia, None; D. ambrosetti, None; J. F. michiels, None; V. Breuil, None; E. Z. Amri, None.

To cite this abstract in AMA style:

roux C, pinzano A, Pisani D, panaia-Ferrari P, Fontas E, Ben Yahia H, ambrosetti D, michiels JF, Breuil V, Amri EZ. Effect of Oxytocin on Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/effect-of-oxytocin-on-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-oxytocin-on-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology